Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-11-16

FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Losartan Potassium 25 mg from Strides Pharma Science Limited, adding a new dosage strength to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium 25 mg (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM 25 MG (LOSARTAN POTASSIUM)